🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Oncopeptides AB (ONCO)

Stockholm
Currency in SEK
1.534
-0.010(-0.65%)
Closed
ONCO Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
1.5061.570
52 wk Range
1.4266.314
Key Statistics
Edit
Prev. Close
1.544
Open
1.542
Day's Range
1.506-1.57
52 wk Range
1.426-6.314
Volume
606.82K
Average Volume (3m)
670.92K
1-Year Change
-75.07%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ONCO Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
2.733
Upside
+78.162%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Oncopeptides Company Profile

Oncopeptides AB (publ), a biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally. Its lead product candidate is Pepaxti (melflufen), a drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. The company also engages in the research for small popypeptide based killer engages for the treatment of RRMM and hematological or solid tumors; and other peptide-drug conjugates for glioblastoma and hematological or solid tumors. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden

Compare ONCO to Peers and Sector

Metrics to compare
ONCO
Peers
Sector
Relationship
P/E Ratio
−1.2x−1.8x−0.7x
PEG Ratio
−0.04−0.020.00
Price/Book
2.4x2.6x2.6x
Price / LTM Sales
12.3x4.5x3.2x
Upside (Analyst Target)
61.9%107.4%47.0%
Fair Value Upside
Unlock29.6%7.5%Unlock

Analysts' Recommendations

1 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 2.733

(+78.18% Upside)

FAQ

What Is the Oncopeptides (ONCO) Stock Price Today?

The Oncopeptides stock price today is 1.534.

What Stock Exchange Does Oncopeptides Trade On?

Oncopeptides is listed and trades on the Stockholm stock exchange.

What Is the Stock Symbol for Oncopeptides?

The stock symbol for Oncopeptides is "ONCO."

What Is the Oncopeptides Market Cap?

As of today, Oncopeptides market cap is 327.08M.

What is Oncopeptides Earnings Per Share?

The Oncopeptides EPS is -2.07.

What Is the Next Oncopeptides Earnings Date?

Oncopeptides will release its next earnings report on 26 Feb 2025.

From a Technical Analysis Perspective, Is ONCO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.